Skip to main content
. 2017 Sep 5;11(9):e0005781. doi: 10.1371/journal.pntd.0005781

Fig 4. The temporal distribution of clinical trials on visceral leishmaniasis drugs.

Fig 4

The cumulative enrolment of patients into clinical studies of VL drugs is shown as a function of the year in which the trial results were published.